"Just like in the software industry, Open Source Pharma can open the doors towards the discovery of innovative and high quality drugs at a fraction of the cost of traditional drugs."
"It's a question of morality and the common good. "
"There is an urgent need of effective research in neglected diseases and crowd sourcing may effectively group together interested people."
"Rise in the number of communicable and non-communicable diseases, and a large proportion of population in the world is not able to afford the treatment due to the high cost. Pharmaceutical companies are shying off development of the drugs in the non-profitable areas, as the development cost of new molecule is very cost intensive."
"Advancement in technology makes everything reachable and affordable for a common man, except healthcare. Medical bills are going high which often disrupt financial balancing of middle income family."
"In today's world, where antibacterial resistance is growing drastically, there is an ever increasing requirement for a revolution in drug discovery. With this looming danger we need to get together in a knowledge sharing platform for creating a healthy tomorrow."
Read what people across the world have to say about why we need a movement like Open Source Pharma. Add to the discussion!
"In the same way open source software revolutionized the field of computational biology, we need open source pharmaceuticals to revolutionize the field of public health."
"In this era of information, a digitalised world, we need actions with high speed with more reliable accurate results, as we all have learned the issues related to antibiotics and resistants towards them by highly mutated pathogens is happening in an alarming rate."
"We need open source pharma for the following reasons:
1) To work together to find drugs/vaccines for neglected diseases like Malaria,TB etc..
2) To create awareness about these diseases to the public.
3) This acts as a platform for science graduates and interested students to get involved in the research projects irrespective of their current employment/position."
"It's one of the global platforms for us students to learn the day to day researches. It's not complicated. I feel free to interact with any member in the group who is a part of it. One of the best motivators for us students."
"Millions of people are unnecessarily dying each year under the current pharmaceutical business model. If we know that an alternative model like OSP can improve the status quo, we have a responsibility as a human race to work towards that objective."
"To provide health care to the poorest of the poor and patients suffering from orphan diseases."
"1) Price to consumers goes down, but pooled risk decreases the investment cost to pharmaceuticals. Pharma companies could then outsource R&D to these and become service driven (FDA approval/ production/ fulfillment)
2) Solutions are adaptable to local contexts (particularly the currently underserved) rather than one-size-fits-all solutions
3) Would promote solutions to small-scale but acute diseases that are currently de-prioritized"
"We simply cannot wait for the next outbreak to realize that something must be done."
"We celebrate financially and socially when we develop drugs and vaccines. There is no need for limiting achievements based on financial or social gain. Let us protect the intellectual achievement of pure research while acknowledging the need for economic recognition of our discoveries, yet avoiding hurting our recipients with excessive billing."
"Luck allows us to be part of the elite 'haves' in healthcare. Courage is what allows us to risk our 'established' status to normalize the disabled amongst us to validate the worthiness of others to be cared for as equals. I am grateful to place myself and my 'pedigree' between the vulnerable refugees and our current political US administration. I may need you to show the world that people like me are worthy of defense of basic human rights. I will put myself between those who prejudge and those who are allowed to judge within our constitution."
-MICHELLE, MD PhD
"Something is wrong here. Medicines keep getting more and more expensive - often times without any apparent reason. In fact: They are not just passively getting more expensive: Someone raises prices. It is the industry behind drug development that does it. How come that they fail so badly? The global R&D model is centered around a market - not around the public health need. Having this in the back of our minds it becomes clear why there was no vaccine ready for Ebola, why the pipeline for new antibiotics is as empty as it possibly could be: It was never the industry's aim to cure or help people in need. The basic goal was to make profit. And here they didn't fail: In fact they are doing really well!"
Montreal, Canada / Berlin, Germany
"Everything that is shared bring people together. The acquisition of knowledge between parties always make the following numerical dogma : 1 +1 = 3. Drugs efficiency has not evolved much in the last decade. Joining forces can only help reaching this goal. Many people cannot afford some drugs, I hope this project can help people buy them."